Tilmann Kramer

1.1k total citations · 1 hit paper
18 papers, 633 citations indexed

About

Tilmann Kramer is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Tilmann Kramer has authored 18 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 13 papers in Cardiology and Cardiovascular Medicine and 1 paper in Molecular Biology. Recurrent topics in Tilmann Kramer's work include Pulmonary Hypertension Research and Treatments (13 papers), Heart Failure Treatment and Management (7 papers) and Cardiovascular Function and Risk Factors (3 papers). Tilmann Kramer is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Heart Failure Treatment and Management (7 papers) and Cardiovascular Function and Risk Factors (3 papers). Tilmann Kramer collaborates with scholars based in Germany, United States and Finland. Tilmann Kramer's co-authors include Stephan Rosenkranz, Christian Opitz, Marius M. Hoeper, Karen M. Olsson, Nicola Benjamin, Dörte Huscher, Christina A. Eichstaedt, Zixuan Pan, Jens Spießhoefer and Ekkehard Grünig and has published in prestigious journals such as Scientific Reports, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Tilmann Kramer

14 papers receiving 625 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

2017 438 citations Marius M. Hoeper, Tilmann Kramer et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tilmann Kramer Germany	8	550	406	93	59	55	18	633
Karin A. Boomars Netherlands	18	488 0.9×	189 0.5×	38 0.4×	83 1.4×	39 0.7×	41	637
Arthur Filusch Germany	11	234 0.4×	296 0.7×	24 0.3×	53 0.9×	17 0.3×	21	460
Marinus A.J. Borgdorff Netherlands	11	363 0.7×	336 0.8×	16 0.2×	86 1.5×	25 0.5×	12	472
Jaime Eduardo Morales-Blanhir Mexico	5	243 0.4×	107 0.3×	16 0.2×	42 0.7×	21 0.4×	14	359
Shuming Wu China	12	156 0.3×	90 0.2×	52 0.6×	96 1.6×	15 0.3×	31	379
Jean‐Marc Schleich France	10	149 0.3×	138 0.3×	23 0.2×	106 1.8×	16 0.3×	31	337
Abdallah Rebeiz Lebanon	9	129 0.2×	148 0.4×	25 0.3×	77 1.3×	13 0.2×	24	264
Jeremy Cailes United Kingdom	7	489 0.9×	159 0.4×	42 0.5×	38 0.6×	16 0.3×	7	564
Thomas N. Martin United Kingdom	11	130 0.2×	423 1.0×	13 0.1×	78 1.3×	7 0.1×	21	507
Kenan İltümür Türkiye	11	75 0.1×	189 0.5×	23 0.2×	54 0.9×	26 0.5×	20	368

Countries citing papers authored by Tilmann Kramer

Since Specialization

Citations

This map shows the geographic impact of Tilmann Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilmann Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilmann Kramer more than expected).

Fields of papers citing papers by Tilmann Kramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilmann Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilmann Kramer. The network helps show where Tilmann Kramer may publish in the future.

Co-authorship network of co-authors of Tilmann Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Tilmann Kramer. A scholar is included among the top collaborators of Tilmann Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilmann Kramer. Tilmann Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kramer, Tilmann, et al.. (2025). Artificial intelligence in pulmonary hypertension: a systematic review. European journal of medical research. 30(1). 1225–1225.

Rosenkranz, Stephan, et al.. (2025). Depression in Pulmonary Hypertension: A Systematic Review of Clinical Outcomes, Treatment Interactions, and Emerging Technologies. Journal of Clinical Medicine. 14(3). 982–982.

Kramer, Tilmann, Ari Heinonen, Jari Parkkari, et al.. (2024). Prevalence of electrocardiographic markers associated with myocardial fibrosis in masters athletes: a cohort study. BMJ Open Sport & Exercise Medicine. 10(3). e001988–e001988.

Kramer, Tilmann, Felix Gerhardt, Daniel Dumitrescu, et al.. (2024). Impact of Rapid Sequential Combination Therapy on Distinct Haemodynamic Measures in Newly Diagnosed Pulmonary Arterial Hypertension. ESC Heart Failure. 11(3). 1540–1552. 4 indexed citations

Kramer, Tilmann, Fabian Hoffmann, Stephan Rosenkranz, et al.. (2023). Electrocardiographic changes during sustained normobaric hypoxia in patients after myocardial infarction. Scientific Reports. 13(1). 17452–17452. 1 indexed citations

Kramer, Tilmann, Paul T. Brinkkoetter, & Stephan Rosenkranz. (2022). Right Heart Function in Cardiorenal Syndrome. Current Heart Failure Reports. 19(6). 386–399. 5 indexed citations

Kramer, Tilmann, Ulrich Limper, Jens Jordan, et al.. (2022). Effects of targeted therapy on blood gas analysis in pulmonary arterial hypertension – a retrospective analysis. European Heart Journal. 43(Supplement_2).

Kramer, Tilmann, Felix Gerhardt, Henrik ten Freyhaus, et al.. (2021). Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term study. Journal of Cachexia Sarcopenia and Muscle. 12(6). 1501–1512. 23 indexed citations

Rosenkranz, Stephan, Tilmann Kramer, Felix Gerhardt, et al.. (2019). Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches. Herz. 44(6). 483–490. 12 indexed citations

10.

Kramer, Tilmann, Daniel Dumitrescu, Felix Gerhardt, et al.. (2019). Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension. International Journal of Cardiology. 283. 152–158. 35 indexed citations

11.

Hohmann, Christopher, Daniel Dumitrescu, Felix Gerhardt, et al.. (2019). High‐risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH‐CHD) with temporary shunt inversion and deoxygenation. Pulmonary Circulation. 9(2). 1–4. 5 indexed citations

12.

Dumitrescu, D., Tilmann Kramer, Felix Gerhardt, et al.. (2018). P1624Intravenous iron substitution improves pulmonary diffusion capacity in patients with iron deficiency and precapillary pulmonary hypertension. European Heart Journal. 39(suppl_1). 1 indexed citations

13.

Kather, Jakob Nikolas, et al.. (2017). Polyphonic sonification of electrocardiography signals for diagnosis of cardiac pathologies. Scientific Reports. 7(1). 44549–44549. 22 indexed citations

14.

Hoeper, Marius M., Tilmann Kramer, Zixuan Pan, et al.. (2017). Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. European Respiratory Journal. 50(2). 1700740–1700740. 438 indexed citations breakdown →

15.

Gerhardt, Felix, Daniel Dumitrescu, Thomas Viethen, et al.. (2017). Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study. Heart. 103(8). 592–598. 30 indexed citations

16.

Dumitrescu, D., Tilmann Kramer, Felix Gerhardt, et al.. (2017). P3531Improvement of pulmonary diffusion capacity after intravenous iron substitution in patients with iron deficiency and pulmonary hypertension. European Heart Journal. 38(suppl_1). 1 indexed citations

17.

Vantler, Marius, Olli Leppänen, Maximilian Scherner, et al.. (2015). Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling. Arteriosclerosis Thrombosis and Vascular Biology. 35(6). 1434–1444. 11 indexed citations

18.

Freyhaus, Henrik ten, Eva Berghausen, Wiebke Janssen, et al.. (2015). Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 35(5). 1236–1245. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact